Journal
MOLECULAR MEDICINE REPORTS
Volume 23, Issue 2, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2020.11785
Keywords
Burkitt lymphoma; long non-coding RNA antisense non-coding RNA in the INK4 locus; TGF-β 1; proliferation; apoptosis
Categories
Funding
- Natural Science Foundation of Liaoning Province [20170540350]
Ask authors/readers for more resources
The knockdown of ANRIL inhibits cell proliferation and promotes apoptosis in Burkitt lymphoma by regulating the TGF-beta 1 signaling pathway, providing a potential novel target for its treatment.
Burkitt lymphoma (BL) has a high mortality rate and its treatment is currently limited to chemotherapy combined with immunotherapy. The long non-coding RNA antisense non-coding RNA in the INK4 locus (ANRIL) has been identified as an oncogene that can regulate cell proliferation and apoptosis in multiple types of cancer. However, the function of ANRIL in BL remains unknown. The present study aimed to determine the effect of ANRIL on cell proliferation and apoptosis in BL. Reverse transcription-quantitative PCR was used to analyze the expression levels of ANRIL in BL cells. The effect of ANRIL knockdown on BL cells was determined using Cell Counting Kit-8, flow cytometric, western blotting, immunofluorescence staining and Hoechst staining assays. The results revealed that ANRIL silencing inhibited the proliferation and promoted the apoptosis of BL cells. In addition, the expression levels of cyclin D1, E2F transcription factor 1 and Bcl-2 were downregulated, while the expression levels of cyclin-dependent kinase inhibitor 1A, Bcl-2-associated X protein, cleaved-caspase-9/pro-caspase-9 and cleaved-caspase-3/pro-caspase-3 were upregulated. Furthermore, the knockdown of ANRIL activated the TGF-beta 1 signaling pathway, as evidenced by the upregulated expression levels of TGF-beta 1, phosphorylated (p)-SMAD2/3/SMAD2/3, p-SMAD1/SMAD1 and sphingosine-1-phosphate receptor 2. Moreover, the protective effect of ANRIL silencing in BL could be inhibited by the TGF-beta receptor type I/II dual inhibitor, LY2109761. In conclusion, the findings of the present study suggested that the knockdown of ANRIL may inhibit cell proliferation and promote cell apoptosis in BL by regulating the TGF-beta 1 signaling pathway, which may provide a novel target for the treatment of BL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available